期刊文献+

同期放化疗与单纯放疗治疗中晚期鼻咽癌的近期疗效

Study of Concurrent Chemoradiotherapy and Radiotherapy Alone for Advanced Nasopharygeal Carcinoma
在线阅读 下载PDF
导出
摘要 目的:评价同期放疗加化疗治疗中晚期鼻咽癌的近期疗效及化疗对放疗副反应的影响。方法:149例初治中晚期鼻咽癌随机分为实验组74例及对照组75例。实验组:采用顺铂与亚叶酸、氟尿嘧啶化疗4周期(分别在放疗前、中、后)。两组的放疗方法及剂量相同,鼻咽部72Gy~78Gy,颈部有淋巴结转移者根治量64Gy~70Gy,颈部预防量50Gy~54Gy。结果:放疗结束时及治疗结束后3个月实验组的鼻咽部及颈部的肿瘤完全消退率均比对照组高,(P<0.05)。实验组出现口腔溃疡、咽喉疼痛、伴吞咽困难及需暂停放疗的发生率比对照组高(P<0.05)。结论:同步放化疗可明显提高晚期鼻咽癌颈部病灶及颈部淋巴结转移灶的消退率,但可加重放疗的不良反应。 Objective Nasopharyngeal carcinoma(NPC) is a radiosensitive and chemosensitive tumor.The aim of this prospective study is to evaluate the efficacy and toxicity of concurrent chemoradiotherapy for advanced NPC.Methods From March 1998 to Augest 2004, 149 cases NPC were randomly allocated into two arms.Similar dosage and fractionation of radiotherapy was administered in both arms.The investigational arm(74 cases) received four cycles of concurrent chemotherapy with cisplatin plus 5-fluorouracil plus leucovorin,during the before and middle and last of radiotherapy.Results The complete response rates of primary tumor and neck nodes in the investigational arm are significantly higher than in the radiotherapy alone arm,P<0.05.The toxicity rates of radiotherapy in the investigational arm are significantly higher than in the radiotherapy alone arm,P<0.05.Conclusion The method of investigational arm is an effective and well-tolerated regimen in the treatment of locally advanced NPC,although there is very much toxicity during radiotherapy.
出处 《实用医技杂志》 2005年第07A期1684-1686,共3页 Journal of Practical Medical Techniques
关键词 鼻咽癌 化学治疗 放射治疗 近期疗效 不良反应 Advaced nasopharygeal carcinoma Radiotherapy Chemotherapy Toxicity Efficacy
  • 相关文献

参考文献7

二级参考文献60

  • 1卢泰祺.低剂量顺铂(DDP)治疗鼻咽癌的临床评价[J].癌症,1989,8(2):109-112. 被引量:9
  • 2胡心传,王者香,王骏业,罗定泰.1,101例鼻咽癌放射治疗的远期疗效及影响疗效因素[J].中国肿瘤临床,1989,16(1):23-25. 被引量:21
  • 3郭小毛,刘瑛,何少琴.放射联合顺铂治疗鼻咽癌的前瞻性临床研究[J].齐鲁肿瘤杂志,1996,3(4):281-282. 被引量:6
  • 4李振权.潘启超,陈剑经,等主编.鼻咽癌临床与实验研究.广州:广东人民出版社,1983.253.
  • 5Zhang EP, Lian PG, Cai KL, et al. Radiationtherapy of nasopharyngeal carcinoma: Prognostic factors based on a 10-year follow-up of 1 302 patients. Int J Radiat Oncol Biol Phys,1989,16(2):301-305.
  • 6Cvitkovic E , Eschwege F , Rahal M, et al. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin,epirubicin,bleomycin) plus radiotherapy vs.radiotherapy alone in stage Ⅳ (≥N2,MO) undifferentiated nasopharyngeal carcinoma:a positive effect on progression-free survival.International Nasopharynx Cancer Study Group.Vumca I Trial. Int J Radiat Oncol Biol Phys,1996,35(3):463-469.
  • 7Turner SL, Tiver KW. Synchronous radiotherapy and chemotherapy in the treatment of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys,1993,27(2):371.
  • 8Chen AT, Teo PM, Leung TW, et al. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyneal carcinoma. Int J Radiat Oncol Phys,1995,33(3):569-577.
  • 9Tubiana M. Tumor cell proliferation kinetics and tumor growth rate. Acta Oncol,1989,28(1):113-121.
  • 10谷铣之,殷蔚伯,刘泰福,等.肿瘤放射治疗学.北京:北京医科大学,中国协和医科大学联合出版社,1993.443.

共引文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部